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Arsenic  exposure  from  burning  high  arsenic-containing  coal has  been  associated  with
human skin  lesion  and  cancer.  However,  the mechanisms  of  arsenic-related  carcinogenesis
are  not  fully  understood.  Inactivation  of  critical  tumor  suppression  genes  by epigenetic  reg-
ulation or  genetic  modiﬁcation  might  contribute  to  arsenic-induced  carcinogenicity.  This
study aims  to clarify  the  correlation  between  arsenic  pollution  and  functional  defect  of
p15INK4b gene  in arsenic  exposure  residents  from  a region  of Guizhou  Province,  China.  To
this  end,  103  arsenic  exposure  residents  and  105  control  subjects  were  recruited  in this
study.  The  results  showed  that  the exposure  group  exhibited  higher  levels  of  urinary  and
hair arsenic  compared  with  the  control  group  (55.28  vs  28.87  g/L,  5.16  vs  1.36  g/g).  Sub-
jects  with  higher  arsenic  concentrations  are  more  likely  to have  p15INK4b methylation  and
gene  deletion  (2 =  4.28,  P =  0.04  and  2 =  4.31,  P = 0.04).  We  also  found  that  the  degree  of
p15INK4b hypermethylation  and  gene  deletion  occurred  at higher  incidence  in  the  poisoning
cases  with  skin  cancer  (3.7%  and  14.81%  in non-skin  cancer  group,  41.18%  and 47.06  in skinChemical  compounds studied in this article:
Arsenic (PubChem CID: 5359596)
cancer group),  and  were  signiﬁcantly  associated  with  the stage  of skin  lesions  (2 =  12.82,
P  <  0.01  and  2 = 7.835,  P  =  0.005).  These  observations  indicate  that  inactivation  of p15INK4b
through  genetic  alteration  or epigenetic  modiﬁcation  is  a common  event  that  is  associated
with  arsenic  exposure  and  the development  of  arsenicosis.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
 BY-NCthe CC
1. Introduction
The inorganic arsenic exposure is a worldwide health
problem. The usage of coal containing high concentrations
of arsenic was reported as a serious environmental pollu-
tion  that causes adverse health effects in China [1–4]. The
unique  cooking style of villagers in Guizhou Province using
high  arsenic content coal in the indoor stove without sufﬁ-
cient  ventilation. More than 200,000 residents exposed to
∗ Corresponding author. Tel.: +86 8516908908; fax: +86 8516908908.
E-mail  addresses: aihuagy@aliyun.com, 940879123@qq.com
(A. Zhang).
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2214-7500/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open a
licenses/by-nc-sa/3.0/).-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
arsenic through diet, inhalation and direct skin contact [2].
The  high incidence of skin lesion and cancer development
was  reported in this region recognized as one of the most
serious endemic arseniasis areas in China [5].
Arsenic is a well-known chemical carcinogen and clas-
siﬁed  as Group 1 carcinogen, which is carcinogenic to
humans, by International Agency for Research on Can-
cer  (IARC) [6]. Although it is evident that chronic arsenic
exposure is associated with human cancers, the mecha-
nism of arsenic-induced carcinogenicity is still not clear.
The  arsenic is considered as a poor mutagen in both bac-
terial  and mammalian mutagenicity assays [7]. However,
arsenic perturbs transcriptional activity and cause aber-
rant  gene expression via generation of reactive oxygen
species (ROS), inhibition of DNA repair, and chromosomal
ccess article under the CC BY-NC-SA license (http://creativecommons.org/
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berration [7,8]. In addition, lines of evidence have shown
hat  the epigenetic regulation such as promoter meth-
lation of tumor suppresser gene is a critical event in
he  course of arsenic-induced carcinogenicity [9–12]. For
xample,  it is supported by both epidemiology and in vivo
tudies  that chronic inorganic arsenic exposure induced
rinary bladder cancer through epigenetic modiﬁcations
uch as DNA methylation [13,14]. Moreover, a number of
tudies  have reported that arsenic exposure results in alter-
tion  of the expression of many important genes such as
RCC2  and CCND 1 [15–17]. Our prior works have linked
uman exposure of arsenic with skin lesions and can-
er  [18–21]. We  found that arsenic exposure affected the
NA  methylation in gene promoters including TP53 [22]
nd  p16 [23], leading to the changes in gene expression
n the chronic arsenic exposure patients [24,25]. Taken
ogether, these ﬁndings support the notion that the dis-
uption  of tumor suppression genes may  contribute to
hronic  arsenic exposure induced carcinogenesis.p15INK4b
s a critical tumor suppressor gene involved in control of
ell  proliferation [26,27]. Aberrant p15 INK4b expression
as been found in many kinds of human tumors including
eukemia, lung and skin cancers [28]. The p15INK4b gene can
e  inactivated by point mutation, homozygous deletion, or
NA  methylation in various human tumors [26,29,30]. The
efect  of p15INK4b is also correlated with tumorigenicity
nduced by chemical carcinogens such as benzo(a)pyrene
31] and benzene [32,33]. In this study, we devote to
ddress whether p15INK4b inactivation contributes to the
evelopment of arseniasis through detection of the expres-
ion  of p15INK4b in arsenic-induced skin lesion tissues and
xamination of the p15INK4b deletion and promoter meth-
lation in peripheral lymphocytes from arsenic-exposed
illagers. Our results indicate that functional defect of
15INK4b gene is associated with the development and pro-
ression of chronic arsenic poisoning.
. Materials and methods
.1.  Study population
The  study areas and subjects recruitment have been
escribed previously in details [23]. Brieﬂy, the residents
se  coal containing high content of arsenic in cooking
nd expose to arsenic via polluted food and air. The 103
rsenic exposure subjects from Jiao Le village in Xinren
ounty, Guizhou Province were recruited. The average age
f  arsenic-exposed group and control group was 49 and
3  years old, respectively. The diagnosis of arsenism was
ade  according to the Chinese National Standard of Arseni-
osis  Diagnosis [34] by medical professionals working in the
orty-fourth Hospital of Chinese People’s Liberation Army.
mong  those 103 arsenic exposure subjects, 44 arsenism
atients were enrolled in the surgical treatment and their
kin  lesions were collected. Served as a control group, 105
ases  were randomly selected in the neighboring Ma  Jiatun
ownship village where residents cooked using coal con-
aining  low arsenic levels and had no signs of arseniasis.
he study proposal was reviewed and approved by the Eth-
cal  Committee of the Guiyang Medical University. Priororts 1 (2014) 692–698 693
to  data collection, written informed consent was obtained
from each participant.
2.2.  Interviews and sample collection
A structured questionnaire was used for recording the
data  on demographic factors, lifestyle and residential his-
tory  of participants. A physical examination was taken by
the  medical professionals. The urine, hair, and peripheral
blood samples were collected. The urinary samples were
stored  at −20 ◦C immediately after collection. Scalp hair
(length, 1 cm)  was  kept in plastic zip lock bags. Fasting
peripheral blood was collected in an EDTA-coated vacuum
tube  and lymphocytes were isolated as soon as the blood
was  drawn. For the patients who  received skin surgery, the
biopsy  skin tissues were collected and subjected to patho-
logical  and immunohistochemistry examinations.
2.3. Arsenic concentrations in hair and urine
Total arsenic content of urine and hair samples were
used for assessing the level of arsenic exposure. All the
urine  and hair samples were analyzed within 1 month after
sample  collection. The details of the analytical method have
been  described previously [20]. Brieﬂy, the hair samples
were ﬁrst washed sequentially with high-purity-deionized
water, then with ethanol and acetone to remove exter-
nal  contaminants. The hair samples were then digested
with concentrated nitric acid (HNO3). Total arsenic con-
tent  in samples was  determined by hydride generation,
inductively coupled plasma atomic emission spectrome-
try (HG-ICP-AES) (Varian Australia, Mulgrave, Australia).
Urinary arsenic concentrations were adjusted by speciﬁc
gravity to equilibrate the differences in urine dilution
[35].
2.4. DNA extraction and methylation-speciﬁc PCR (MSP)
Genomic DNA is isolated from the lymphocytes of
the  subjects. To perform MSP, 2 g DNA was dena-
tured by freshly prepared 2 mol/L NaOH, mixed with
30  l of 10 mmol/L freshly prepared hydroquinone and
500  l of 3 mol/L freshly prepared sodium bisulfate
(pH5.0) and then incubated at 55 ◦C for 16 h in dark.
The DNA was puriﬁed by DNA Wizard clean-up resin,
and desulfonated by adding NaOH. Finally, DNA was
precipitated by ethanol and dissolved in sterile dis-
tilled water. This modiﬁed DNA was  used for PCR
ampliﬁcation by unmethylation speciﬁc primers (for-
wards: 5′-TGTGATGTGTTTGTATTTTGTGGTT-3′; reverse:
5′-CCATACAAT AACCAAACA ACCAA-3′) and methylation
speciﬁc primers (forwards: 5′-GCGTTC GTATTTTGCGGTT-
3′; reverse: 5′-CGTACAATAACCGAACGACCGA-3′). Two
fragments, 148 bp and 154 bp that represents unmethy-
lated and methylated signaling, respectively was  expected
to  appear after ampliﬁcation. The CpG methyltransferase,
M.SssI, treated human placental DNA served as a positive
control.
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2.5. Homozygous deletion detection by multiplex PCR
Homozygous deletion at the ﬁrst and second
exons of p15INK4b was analyzed by multiplex PCR.
The primers used for ampliﬁcation are as follow: for-
wards 5′-CCAGAAGCAATCCAGGCGCG-3′ and reverse:
5′-AATGCACACCTCGCC AACG-3′ for exon 1 (532 bp);
and  forwards: 5′-CTTTAAATGGCTCCACCTGC-3′, and
reverse: 5′-CGTTGGCAGCCTTCATCG-3′ for exon 2
(437  bp). A fragment (303 bp) of -actin gene (for-
wards: 5′-GAAACTACCTTCAACTCCATC-3′, and reverse:
5′-CTAGAAGCTTTTGCGGACGATGGAGGGGCC-3′) was used
as  an internal standard. All multiplex reactions were made
in  a total volume of 25 l containing MgCl2 (2 mM), dNTP
(200 M),  1.25 U Taq DNA polymerase (Takara, Dalian,
China) and speciﬁc reverse primers (0.2 M each) in the
polymerase buffer. PCR cycles were preceded by an initial
denaturation at 94 ◦C for 5 min, then reactions were run
for  35 cycles of 95 ◦C for 45 s, 60 ◦C (exon 1) or 57 ◦C (exon
2) for 45 s and 72 ◦C for 1 min, and completed by a ﬁnal
elongation at 72 ◦C for 7 min.
2.6. Statistical analysis
The  Statistical Package for the SPSS version 16.0 (SPSS
Inc.,  Chicago, IL, USA) was used for statistical analysis. The
concentrations of the urinary and hair arsenic were used as
continuous  measures and also categorized into tertiles. The
arsenism  patients were classiﬁed as “mild,” “intermediate”
and “severe” based on the degree of skin lesions according
to  the Chinese National Standard of Arsenicosis Diagnosis
[34].
Independent-samples t-test was used to compare the
age,  urinary and hair arsenic levels between arsenism and
the  control group. The bivariate correlations were used
to  assess the relationships between the concentrations of
arsenic  and potentially important covariates, such as age
Table 1
Demographic data of the subjects and biomarkers analyzed.
Variables Controls
No. (%) or Mean ± SD
Epidemiological characteristics
Number  103 
Age 
≥40 45 (43.69) 
<40 58 (56.31) 
Sex 
Male 58 (56.31) 
Female 45 (43.69) 
Smoking 
No 41 (39.8) 
Yes 62 (60.2) 
Alcohol use 
No 56 (54.36) 
Yes 47 (45.64) 
Arsenic exposure and p15INK4b
p15INK4b deletion (%) 16 (15.53) 
p15INK4b methylation (%) 3 (2.91) 
Urinary Arsenic (g/L) 28.8 ± 1.64 
Hair Arsenic (g/g) 1.36 ± 0.20 
Data are expressed as mean ± SD or No. (%).
a Two-tailed 2 test.
b Independent-samples t-test.orts 1 (2014) 692–698
and  smoking status. To analyze the associations between
tertiles of urinary and hair arsenic and trichotomous skin
lesions  and the frequencies of p15INK4b methylation and
deletion, the trend 2 tests were performed.
3. Results
3.1. Epidemiological characteristics
The  characteristics of the study population are
described in Table 1, providing the information regarding
age,  sex, smoking and alcohol use in the controls and
arsenic-exposed group. No signiﬁcant differences were
found  in all these characteristics between two  group people
after  statistical analysis.
3.2.  Case-control study in arsenic exposure
The presence of arsenic in urine is an indication of recent
exposure (approximately within days), while arsenic in
hair  or ﬁngernails is of exposure within 3-6months [36]. As
shown  in Table 1, the total arsenic contents of both urine
and  hair samples were signiﬁcantly higher in arsenic expo-
sure  group than that in controls. The average content of
urinary  arsenic in exposure group is 1.92 fold higher that
in  control group (P < 0.01, independent-samples t-tests). In
parallel,  the average content of hair arsenic in exposure
group is 3.79 fold higher than that in control group (P < 0.01,
independent-samples t-tests). These observations conﬁrm
the  high level of exposure in arseniasis subjects.
3.3. Arsenic exposure is associated with hypermylation of
p15INK4bDNA methylation of the p15INK4b genes is detected
in 14 (13.33%) of arseniasis patients and 3 (2.91%) of
control, respectively (Table 1). The degrees of p15INK4b
Arsenic exposure
No.  (%) or Mean ± SD
P
105
0.38a
38 (36.19)
67 (63.81)
0.50a
64 (60.95)
41 (39.05)
0.56 a
46 (43.81)
59 (56.19)
0.77 a
55 (52.38)
50 (47.62)
31 (29.52) 0.02a
14 (13.33) 0.04a
55.28 ± 1.89 <0.01b
5.16 ± 0.62 <0.01b
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Table 2
Correlations between arsenic exposure and deletion or promoter methylation of p15INK4b .
N p15INK4b deletion (%) 2 P p15INK4b methylation (%) 2 P
Urinary Arsenic (g/L)
0–<40  26 5 (19.23) 4.90 0.03a 2 (7.69) 2.08 0.15a
40–<80 36 12 (33.33) 6 (16.67)
80– 27  13(48.15) 6 (22.22)
Hair  Arsenic (g/g)
0–<3  34 7 (20.59) 4.31 0.04a 2 (2.88) 4.28 0.04a
3–<6 30 9 (30.00) 4 (13.33)
6–  34 15 (44.12) 8 (23.53)
Data are expressed as No. (%).
a Two-tailed 2 test.
Table 3
Correlations between the severity of the arsenic poisoning and deletion or promoter methylation of p15INK4b .
N p15INK4b deletion (%) 2 P p15INK4b methylation (%) 2 P
Control 103 16(15.53) 7.84 0.01a 3(2.91) 12.82 0.00a
Mild 35 8(22.88) 2(5.71)
Intermediate  44 13(29.55) 6(13.64)
Severe 26 10(38.46) 6(23.08)
Histology
Non-skin  cancers 27 4(14.81) 0.04a 1(3.70) 0.00a
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ata are expressed as No. (%).
a Two-tailed 2 test.
ethylation were not signiﬁcantly different in terms of
exes  or age between two groups (data not show). The
xposure subjects were divided into three subgroups
ccording to the content of urinary arsenic (<40 g/L,
80 g/L and ≥80 g/L, respectively) and to the content
f hair arsenic (<3 g/L, <6 g/L and ≥6 g/L, respectively).
he rates of methylation of p15INK4b promoter are positively
orrelated with the increasing levels of hair arsenic expo-
ure  (two-tailed 2 test, P < 0.05), but not correlated with
he  urinary arsenic exposure. These results revealed that
igher  levels of arsenic exposure might be associated with
ypermethylation of p15INK4b.
.4. Arsenic exposure is associated with p15INK4b gene
eletions
As shown in Table 1, homozygous deletions of the
15INK4b genes in at least one exon are detected in 31
29.52%) of arseniasis patients and 16 (15.53%) of control.
he  degree of p15INK4b homozygous deletion was not sig-
iﬁcantly different in terms of sex or age between two
roups (data not shown). The frequency of p15INK4b gene
eletion (at least one exon) is much higher in the highest
rinary arsenic subgroup (48.15%) compared to the low uri-
ary  arsenic subgroup (9.23%) (two-tailed 2 test, P < 0.05).
imilar  results were also found when the comparison per-
ormed  between the frequency of p15INK4b deletion and
he  amounts of hair arsenic exposure (two-tailed 2 test,
 < 0.05) (Table 2).
.5. p15INK4b methylation and homozygous deletion are
orrelated with the severity of arsenic poisoning
Next we determine whether functional defect of
15INK4b resulting from promoter methylation or7(41.18)
homozygous deletion is associated with signs of clin-
ical  arsenic poisoning. Based on the Chinese National
Standard of Arsenicosis Diagnosis, we  divided the subjects
into  four groups based on the severity of the poisoning,
control, mild, intermediate, and severe. We  also divided
the  subjects into two  groups, non-skin cancers and skin
cancers. Factors such as gender, age, smoking or drinking
status had no impact on p15INK4b methylation and gene
deletion (data not shown). As a result, we  found that
the  stage of skin lesions was  positively correlated with
the  rates of promoter methylation and the deletions of
p15INK4b (two-tailed 2 test, P < 0.05). Moreover, the extent
of p15INK4b methylation and deletion is signiﬁcantly higher
in  the patients with skin cancers than non-skin cancers
(P  < 0.05) (Table 3). Taken together, these observations
reveal that the inactivation of p15INK4b is relative with the
stage of the arsenicosis.
4.  Discussion
Indoor coal use becomes one of the most serious envi-
ronmental problems in China [1,37–39]. Previously, we
reported a severe arsenic pollution village named Jiao Le
in  Guizhou Province, where numerous arsenicosis cases
appeared with the skin lesion or skin cancers [40,41]. To
explore  the mechanisms of arsenic poisoning and related
carcinogenicity, here we  conduct a case-control study
and  demonstrate that arsenic exposure is associated with
p15INK4b inactivation via DNA methylation and gene dele-
tionsin Guizhou residents. These ﬁndings provide new
insight into the role of p15INK4b in arsenicosis.The disruption of tumor suppression genes is a piv-
otal mechanism of arsenic carcinogenesis in both human
and  experimental studies. Our previous works have linked
human  exposure to arsenic coal ﬁre with the skin lesions
ogy Rep
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and cancers. The alterations in gene expression of two
important tumor suppressor genes, p16 [23] and p53 [22]
have  been identiﬁed in samples of arsenic exposure resi-
dents.  Adding to the previous ﬁndings, here we identify a
novel  gene p15INK4b whose inactivation might be involved
in adverse health outcome induced by arsenic exposure.
The  suppression or deletions of p15INK4b are found in
numerous tumors such as hepatocellular carcinomas [42],
basal  cell carcinoma [43] and primary lymphoid malig-
nancies [44]. It has been reported that p15INK4b exhibits
an antitumor effect in basal cell carcinoma by inducing
growth arrest and apoptosis in both in vitro and in vivo
studies [26,27]. Recent studies have shown that both DNA
methylation status and deletions of p15INK4b affect the
expression of genes [31,45]. DNA hypermethylation occurs
often  in the promoter region of gene and leads to a trans-
criptional silencing of the genes found in mutilate tumors
[46].  Arsenic has been found to cause changes in globe
genome DNA methylation status in animal experiments
and humans [47–49]. With respect to tumor suppres-
sor genes, prior studies showed that inorganic arsenic
exposure induced signiﬁcant DNA hypermethylation in
tumor  suppressor gene p53 [50–52] and p16INK2a [23,53].
In this study, we demonstrate a tendency of p15INK4b
hypermethylation in arsenic exposed population in a dose-
dependent manner. This tendency also appears in the skin
lesion  tissues, correlating with the stage of illness. It indi-
cates  that alteration of the DNA methylation of critical
genes may  be a plausible mechanism of arsenic-induced
malignancy. Although the mechanism of DNA hypermeth-
ylation after arsenic exposure remains elusive, prior studies
revealed  that arsenic exposure could directly affect DNA
cytosine methyltransferases and result in a change in
whole  genomic DNA methylation [54,55]. Further studies
are  required to address the critical pathways that trigger
arsenic exposure-related epigenetic modiﬁcation.
The deletion in p15INK4b exons in arsenicosis cases is cor-
related with the levels of arsenic exposure. Homozygous
deletion of the p15INK4b gene has been proved as a com-
mon  event in certain human primary tumors [30,56–59].
Here we ﬁnd that the deletion of p15INK4b gene existing
in exposed group is nearly twice as much as those in the
control  subjects. Although prior studies do not provide
strong evidence that arsenic is a direct mutagen [7,8], we
speculate  that the mechanisms including oxidative damage
[60,61],  DNA repair inhibition [62] and genome instabil-
ity  [60] might contribute to arsenic-induced genotoxicity.
Furthermore, we could not eliminate the possibility that
genetic  mutations detected in our study subjects might
be  due to the existence of other environmental hazards as
demonstrated in previous studies [63–65].
Adding to our previous ﬁndings, these observa-
tions indicate that the inactivation of INK4b/ARF/INK4a
locus is likely associated with chronic arsenic poison-
ing. It is known that p15INK4b and p16INK2a locate in
INK4b/ARF/INK4a locus and function as redundant gene.
Importantly, both p15INK4b and p16INK2a genes have been
recognized as tumor suppression genes [66]. Our prior
works have showed that arsenic exposure leads to a defect
of  p16INK2a gene [23]. Taken together, we speculate that the
locus  of INK4b/ARF/INK4a is the target of arsenic-induced
[orts 1 (2014) 692–698
genetic or epigenetic modiﬁcations. The functional defects
of  INK4b/ARF/INK4a might be attributable to arsenic-
induced adverse health effects.
5. Conclusions
In conclusion, this study demonstrates that inactivation
of p15INK4b gene via DNA methylation or genetic mutation
may  result from human arsenic exposure and contribute to
the  development of arsenicosis.
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